How Altasciences Provides Solutions for Substance Abuse Studies

1. How Altasciences Provides Solutions for Substance Abuse Studies

2. How Altasciences Provides Solutions for Substance Abuse Studies Altasciences offers comprehensive solutions for human abuse potential (HAP) and substance abuse studies, with experience conducting nearly 50 studies in the U.S. and Canada. Their research has included studies for stimulants, opioids, cannabinoids, nicotine, and sedative hypnotics. As a leader in CNS clinical trials, Altasciences offers in-depth clinical expertise and thorough processes. Here’s how their experience can help you conduct your next study. Top-Tier Facilities Altasciences has designed and built ideal facilities for studies on addiction behavior. These facilities give you access to the resources you need to conduct craving and withdrawal assessments, pharmacokinetic analysis of drugs, and abuse liability. As part of Altasciences’ three clinical facilities in North America and total of 580 beds, Altasciences’ clinical pharmacology unit in Kansas City is reconfigurable and adaptable, and includes a 30-bed, self- contained, and locked unit, which is incorporated into the overall footprint of a 140-bed general population research campus.

3. This is the perfect size for conducting your trials, especially when monitoring adverse events (AEs), managing critical endpoints, and performing complex medical procedures. Plus, every aspect of the study environment can be controlled as it relates to study participants or specific protocol requirements. No matter what you have planned, Altasciences offers a full range of bioanalytical services in their state-of-the-art facilities throughout the U.S. and Canada to help streamline your research. Clinical Research Pharmacists Some clinical research pharmacists specialize in abuse-deterrent preparation and manipulation training, such as those at Altasciences. Altasciences’ pharmacists also have vast experience in formulating and dosing through all routes of administration (including oral, sublingual, intranasal, and parenteral). Other skills include over-encapsulation, manipulation and usability processing of abuse-deterrent oral dosage forms, handling and storing controlled substances, and the blinding of referenced and comparator products. Altasciences works with clients developing CNS compounds to incorporate critical regulatory decisions and requirements into their clinical development programs as early as possible. Altasciences’ proactive approach with regulatory agencies means they are always updated on the latest requirements. As a result, they can offer effective advice to clients on their study design and execution. Team of Internationally Recognized Experts in HAP The Altasciences team consists of internationally recognized drug development experts in the fields of pharmacology, abuse and addiction, and regulatory requirements. They provide integral support in building your plan for early clinical development and target product profile to ensure that data and comprehensive studies are collected early in drug development. This helps you meet regulatory milestones and offers support during meetings with the FDA and other regulatory agencies worldwide. Appropriate data collection also helps determine whether dedicated studies evaluating abuse potential, driving impairment, and QT prolongation will be required or waived by regulators. The team at Altasciences will help strategically evaluate your program to ensure efficiency and timely decision-making for drug development and drug approval. In addition to human abuse potential (HAP) studies, Altasciences offers a wealth of experience in many other areas that are beneficial to pharmaceutical and biotechnology companies, including first in human clinical trials, pharmacokinetics in special populations, proof of concept studies, and driving simulations.

4. For https://www.altasciences.com/ HAP and substance abuse study expertise, contact Altasciences at Original Source: https://bit.ly/3M70Mab